Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H 37 RV MTB inhibitors

Chemical Biology and Drug Design

Volumn 82, Issue 6, 2013, Pages 669-684

  Khunt, Ranjan C ^a   Khedkar, Vijay M ^b   Coutinho, Evans C ^b  

^a SAURASHTRA UNIVERSITY   (India)

^b BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

3D QSAR; Antitubercular activity; Chloroquinolines

Indexed keywords

CHLOROQUINE; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PHARMACOPHORE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

3D-QSAR; ANTITUBERCULAR ACTIVITY; CHLOROQUINOLINES;

ANTITUBERCULAR AGENTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; QUINOLINES;

EID: 84889804427     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12178     Document Type: Article

References (32)

1. Asgharzadeh M., Kafil H.S., (2007) Current trends in molecular epidemiology studies of Mycobacterium tuberculosis. Biotechnol Mol Biol Rev; 2: 108-115.
2. Chakraborty A.K., (2004) Epidemiology of tuberculosis: current status in India. Indian J Med Res; 120: 248-276.
3. World Health Organization. (2007) Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report 2008. Geneva, Switzerland: World Health Organization.
4. Scior T., Meneses Morales I., Garces Eisele S.J., Domeyer D., Laufer S., (2002) Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis-a review. Arch Pharm (Weinheim); 335: 511-525.
5. Iseman M.D., (2002) Tuberculosis therapy: past, present and future. Eur Respir J Suppl; 36: 87s-94s.
6. Ginsberg A.M., (2008) Emerging drugs for active tuberculosis. Semin Respir Crit Care Med; 29: 552-559.
7. Tripathi R.P., Tewari N., Dwivedi N., Tiwari V.K., (2005) Fighting tuberculosis: an old disease with new challenges. Med Res Rev; 25: 93-131.
8. Nikonenko B.V., Protopopova M., Samala R., Einck L., Nacy C.A., (2007) Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs. Antimicrob Agents Chemother; 51: 1563-1565.
9. Gelber R., Andries K., Paredes R.M.D., Andaya C.E.S., Burgos J., (2009) The diarylquinoline R207910 is bactericidal against Mycobacterium leprae in mice at low dose and administered intermittently. Antimicrob Agents Chemother; 53: 3989.
10. Molina P., Aller E., Lorenzo A., Lõpez-Cremades P., Rioja I., Ubeda A., Terencio M.C., Alcaraz M.J., (2001) Solid-phase synthesis and inhibitory effects of some pyrido[1,2-c]pyrimidine derivatives on leukocyte formations and experimental inflammation. J Med Chem; 44: 1011-1014.
11. Bhardwaj S.D., Jolly V.S., (1997) Synthesis, anti-HIV and anticancer activities of some new formazans. Asian J Chem; 9: 48-51.
12. Nayyar A., Monga V., Malde A., Coutinho E., Jain R., (2007) Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2- substituted quinolines. Bioorg Med Chem; 15: 626-640.
13. Nayyar A., Malde A., Jain R., Coutinho E., (2006) 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents. Bioorg Med Chem; 14: 847-856.
14. Nayyar A., Malde A., Coutinho E., Jain R., (2006) Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4- quinolinecarbaldehyde derivatives. Bioorg Med Chem; 14: 7302-7310.
15. Ubiali D., Pagani G., Pregnolato M., Piersimoni C., Pedraz Munoz J.L., Rodriguez Gascon A., Terreni M., (2002) New N-alkyl-1,2-dihydro-2-thioxo-3- pyridinecarbothioamides as antituberculous agents with improved pharmacokinetics. Bioorg Med Chem Lett; 12: 2541-2544.
16. Rosowsky A., Forsch R.A., Queener S.F., (2002) Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim. J Med Chem; 45: 233-241.
17. Desai B., Sureja D., Naliapara Y., Shah A., Saxena A.K., (2001) Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents. Bioorg Med Chem; 9: 1993-1998.
18. Khunt R.C., Khedkar V.M., Chawda R.S., Chauhan N.A., Parikh A.R., Coutinho E.C., (2012) Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives. Bioorg Med Chem Lett; 22: 666-678.
19. Cramer R.D. III, Patterson D.E., Bunce J.D., (1988) Comparative molecular field analysis (CoMFA). I. effect of shape on binding of steroids to carrier proteins. J Am Chem Soc; 110: 5959-5967.
20. Cramer R.D. III, Patterson D.E., Bunce J.D., (1989) Recent advances in comparative molecular field analysis (CoMFA). Prog Clin Biol Res; 291: 161-165.
21. Klebe G., Abraham U., Mietzner T., (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem; 37: 4130-4146.
22. Klebe G., (1998) Comparative molecular similarity indices analysis: CoMSIA. Perspect Drug Discov Design; 12: 87-104.
23. Klebe G., Abraham U., (1999) Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. J Comput Aided Mol Des; 13: 1-10.
24. Yajko D.M., Madej J.J., Lancaster M.V., Sanders C.A., Cawthon V.L., Gee B., Babst A., Hadley W.K., (1995) Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol; 33: 2324-2327.
25. Suling W.J., Seitz L.E., Pathak V., Westbrook L., Barrow E.W., Zywno-Van-Ginkel S., Reynolds R.C., Piper J.R., Barrow W.W., (2000) Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase. Antimicrob Agents Chemother; 44: 2784-2793.
26. Manvar A., Malde A., Verma J., Virsodia V., Mishra A., Upadhyay K., Acharya H., Coutinho E., Shah A., (2008) Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides. Eur J Med Chem; 43: 2395-2403.
27. Golbraikh A., Tropsha A., (2002) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J Comput Aided Mol Des; 16: 357-369.
28. Wold S., Johansson E., Cocchi M., (1993) PLS: partial least squares projections to latent structures. In:, Kubinyi H., editor. PLS: Partial Least Squares Projections to Latent Structures. Leiden: ESCOM Science Publishers; p. 523-550.
29. Stone M., (1974) Cross-validatory choice and assessment of statistical predictions. J Roy Stat Soc B; 36: 111-147.
30. Richard D., Cramer R.D. III, Bunce J.D., Patterson D.E., Frank I.E., (1988) Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct-Act Relat; 7: 18-25.
31. Shao J., (1996) Bootstrap model selection. J Am Stat Assoc; 91: 655-665.
32. Rucker C., Rucker G., Meringer M., (2007) y-Randomization and its variants in QSPR/QSAR. J Chem Inf Model; 47: 2345-2357.